Skip to main content
BMC Urology logoLink to BMC Urology
. 2017 Mar 28;17:20. doi: 10.1186/s12894-017-0210-x

Erratum to: Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment

Hiroji Uemura 1, Nobuaki Matsubara 2, Go Kimura 3, Akito Yamaguchi 4, Dianne Athene Ledesma 5, Marco DiBonaventura 6, Ateesha F Mohamed 7, Enrique Basurto 6, Ian McKinnon 6, Ed Wang 7, Kristen Concialdi 6, Aya Narimatsu 5, Yasuko Aitoku 5,
PMCID: PMC5371215  PMID: 28351390

Erratum

After publication of this work [1] it was noticed that there was a typographical error in the Conclusions. The letter ‘a’ in ‘asymtoptomatic’ should have been removed in the concluding statement as it is inconsistent with the Results and Discussion. The statement in the Conclusions should read: ‘Patients who were symptomatic placed significantly more importance on delaying an SSE when expressing medication preferences.’

The original article was corrected. The publisher apologises for this error.

Footnotes

The online version of the original article can be found under doi:10.1186/s12894-016-0182-2.

Reference

  • 1.Uemura H, Matsubara N, Kimura G, Yamaguchi A, Ledesma DA, DiBonaventura M, et al. Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment. BMC Urol. 2016;16:63. doi: 10.1186/s12894-016-0182-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Urology are provided here courtesy of BMC

RESOURCES